Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04310826 · ClinicalTrials.gov registry record · NA
Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy
A NA study of Ovarian Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT04310826 is a NA study of Ovarian Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 26 participants, below the 3,243-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04310826, a NA study of Ovarian Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well a diet high in magnesium works in preventing low blood magnesium levels (hypomagnesemia) in patients with ovarian cancer receiving carboplatin chemotherapy. Hypomagnesemia is a common side effect of carboplatin-containing chemotherapy. A magnesium rich diet may increase the levels of magnesium in the blood and help prevent hypomagnesemia resulting from carboplatin chemotherapy.
Conditions Studied
Interventions
- OTHER Media Intervention
- DIETARY_SUPPLEMENT Dietary Intervention
- BEHAVIORAL Telephone-Based Intervention
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-04-23 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04310826
The ClinicalTrials.gov registry entry for NCT04310826 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,243-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (99% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ovarian Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Media Intervention is the first listed.
NCT04310826 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04310826 about?
NCT04310826 is a clinical study titled "Dietary Magnesium in Preventing Low Blood Magnesium Levels in Patients With Ovarian Cancer Receiving Carboplatin Chemotherapy". This trial studies how well a diet high in magnesium works in preventing low blood magnesium levels (hypomagnesemia) in patients with ovarian cancer receiving carboplatin chemotherapy. Hypomagnesemia is a common side effect of carboplatin-containing chemotherapy. A magnesium rich diet may increase t...
What is the current status of trial NCT04310826?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2019-04-23. Estimated completion is 2026-04-01.
What conditions does trial NCT04310826 study?
This clinical trial studies the following conditions: Ovarian Carcinoma.
What interventions are being tested in trial NCT04310826?
The interventions under investigation include: Media Intervention (OTHER), Dietary Intervention (DIETARY_SUPPLEMENT), Telephone-Based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04310826?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04310826 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
RECRUITING · NA
-
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
RECRUITING · NA
-
Access to Genetic Testing in Underserved Patients With Cancer
RECRUITING · NA
-
The Vanguard Study: Testing a New Way to Screen for Cancer
RECRUITING · NA
-
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.